NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP), a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that its management met with Colombia’s President Alvaro Uribe and the country’s Vice-Minister of Health, Carlos Cuervo Valencia at the Presidential Palace in Bogota last week. Pro-Pharmaceuticals was joined by executives from its Colombian marketing and distribution partner, PROCAPS S.A., to further demonstrate their commitment to improving the experience and results of chemotherapy treatment, through the use of DAVANAT®.
